Artificial intelligence and the development of antibody drugs

Aysha Mendes looks at the implications for prescribers of AI-designed therapies, which could expand treatment choices and accelerate development, reducing the long delays patients often face before therapies reach them

Authors

Alexandra Mendes (ORCID: https://orcid.org/0000-0001-8060-5920)

Publication Details

Journal: Journal of Prescribing Practice
Published: 2025-10-02
DOI: https://doi.org/10.12968/jprp.2025.0119
Primary Topic: Monoclonal and Polyclonal Antibodies Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Artificial intelligence and the development of antibody drugs

Alexandra Mendes

Oct 2, 2025

Journal of Prescribing Practice

Monoclonal and Polyclonal Antibodies Research

article

Artificial intelligence and the development of antibody drugs

Alexandra Mendes

October 2, 2025article en

Abstract

Journal of Prescribing PracticeVol. 7(10)

Openalex Percentile: Top 58%

Monoclonal and Polyclonal Antibodies Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Artificial intelligence and the development of antibody drugs — Alexandra Mendes · Journal of Prescribing Practice (2025) | TGRS Research Map | TGRS